Wealthfront Advisers LLC Eli Lilly & CO Transaction History

Wealthfront Advisers LLC

$32.2 Billion
Q3 2024

A detailed history of Wealthfront Advisers LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Wealthfront Advisers LLC holds 103,845 shares of LLY stock, worth $83.1 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

103,845

Previous 105,217 1.3%

Holding current value

$83.1 Million

Previous $95.3 Million 3.42%

% of portfolio

0.29%

Previous 0.32%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $1.06 Million - $1.32 Million	-1,372 Reduced 1.3%	103,845 $92 Million
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $674,129 - $845,407	-930 Reduced 0.88%	105,217 $95.3 Million
Q1 2024 Apr 19, 2024	SELL	$592.2 - $792.28 $331,632 - $443,676	-560 Reduced 0.52%	106,147 $82.6 Million
Q4 2023 Feb 09, 2024	BUY	$525.19 - $619.13 $279,926 - $329,996	533 Added 0.5%	106,707 $62.2 Million
Q3 2023 Nov 01, 2023	SELL	$434.7 - $599.3 $960,252 - $1.32 Million	-2,209 Reduced 2.04%	106,174 $57 Million
Q2 2023 Aug 07, 2023	BUY	$350.74 - $468.98 $690,607 - $923,421	1,969 Added 1.85%	108,383 $50.8 Million
Q1 2023 Apr 28, 2023	SELL	$310.63 - $364.82 $1.56 Million - $1.83 Million	-5,006 Reduced 4.49%	106,414 $36.5 Million
Q4 2022 Feb 10, 2023	BUY	$321.55 - $374.67 $447,276 - $521,165	1,391 Added 1.26%	111,420 $40.8 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $833,405 - $949,752	2,811 Added 2.62%	110,029 $35.6 Million
Q2 2022 Jul 20, 2022	BUY	$278.73 - $327.27 $6.66 Million - $7.82 Million	23,903 Added 28.69%	107,218 $34.8 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $3.47 Million - $4.32 Million	14,806 Added 21.61%	83,315 $23.9 Million
Q4 2021 Jan 21, 2022	BUY	$224.85 - $279.04 $1.85 Million - $2.29 Million	8,217 Added 13.63%	68,509 $18.9 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $1.26 Million - $1.55 Million	5,678 Added 10.4%	60,292 $13.9 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $591,301 - $764,843	3,275 Added 6.38%	54,614 $12.5 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $804,510 - $1.04 Million	4,896 Added 10.54%	51,339 $9.59 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $713,355 - $943,940	-5,468 Reduced 10.53%	46,443 $7.84 Million
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $130,574 - $151,033	893 Added 1.75%	51,911 $7.68 Million
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $470,239 - $565,928	3,447 Added 7.25%	51,018 $8.38 Million
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $1.43 Million - $1.77 Million	12,036 Added 33.87%	47,571 $6.6 Million
Q4 2019 Jan 21, 2020	SELL	$106.92 - $132.43 $690,917 - $855,762	-6,462 Reduced 15.39%	35,535 $4.67 Million
Q3 2019 Oct 15, 2019	SELL	$106.79 - $116.16 $788,857 - $858,073	-7,387 Reduced 14.96%	41,997 $4.7 Million
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $834,137 - $973,650	-7,529 Reduced 13.23%	49,384 $5.47 Million
Q1 2019 May 13, 2019	BUY	$111.31 - $131.02 $351,739 - $414,023	3,160 Added 5.88%	56,913 $7.39 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $5.69 Million - $6.38 Million	53,753 New	53,753 $6.22 Million

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $760B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthfront Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthfront Advisers LLC with notifications on news.

Account

Wealthfront Advisers LLC Eli Lilly & CO Transaction History